We welcome this important research from @icrlondon.bsky.social & St Mark's Hospital. They've found a way to predict #BowelCancer risk in people with #InflammatoryBowelDisease. This could help guide treatment & colonoscopy frequency and may lead to more personalised care for those with #PSC-IBD

Starting to come up with ideas for #20kyourway #pscsupport #LiverSky #PSC

🎆Research granted🎆 Grants always carry a sense of responsibility, but receiving one from a patient organization takes this to a whole new level PSC Support decided to support our project Multiomics data for personalised PSC prognosis #PSCSupport #AI #Personnalised_medicine #Hepatology

2025 is the perfect year to take your career to the next level🚀 There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force. Apply by 20 January: easl.eu/leadership25 #LiverSky

Welcome to BlueSky Martine Walmsley, Head of Research Strategy PSC Support @f8martine.bsky.social. Check out our growing PSC Starter Pack (I've added you!) go.bsky.app/6hLJsJT Please suggest any new PSC people to add. #PSC

New work from us: Oral vancomycin is associated with attenuation in IBD activity in people with PSC. We also studied changes in gut microbiome profile, and key transcriptomic and metabolomic features. academic.oup.com/ecco-jcc/adv...

Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in #BMJOpen: doi.org/10.1136/bmjo... @pscsupport.bsky.social @cholestasisdoc.bsky.social